z-logo
open-access-imgOpen Access
TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling
Author(s) -
Ting Zhao,
Zhenyu Wang,
Yehong Chi,
Chunmei Ni,
Xudan Zheng
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10706
Subject(s) - gene knockdown , angiotensin ii , atrial natriuretic peptide , ampk , endocrinology , pressure overload , medicine , biology , brain natriuretic peptide , blot , transfection , muscle hypertrophy , pi3k/akt/mtor pathway , protein kinase a , phosphorylation , apoptosis , signal transduction , microbiology and biotechnology , heart failure , biochemistry , blood pressure , gene , cardiac hypertrophy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom